Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide
- 1 April 2014
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 10 (3) , 609-618
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in MicePLOS ONE, 2012
- Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxisAntiviral Research, 2012
- Microbicides: still a long road to successTrends in Microbiology, 2012
- Overview of microbicides for the prevention of human immunodeficiency virusBest Practice & Research Clinical Obstetrics & Gynaecology, 2012
- HIV vaccine development: Challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problemVaccine, 2012
- Microbicides: Topical Prevention against HIVCold Spring Harbor Perspectives in Medicine, 2011
- The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatmentRetrovirology, 2011
- Ex Vivo Comparison of Microbicide Efficacies for Preventing HIV-1 Genomic Integration in Intraepithelial Vaginal CellsAntimicrobial Agents and Chemotherapy, 2010
- Vaginal microbicides and the prevention of HIV transmissionThe Lancet Infectious Diseases, 2008
- HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentThe Lancet, 2006